GCG and diabetes mellitus: With the goal of not only controlling diabetes but targeting improvements in Metabolic Syndrome, we leveraged the incretin and amylin classes of therapeutic hormones to create a molecule that could generate equal or better glucose control compared to exenatide with the added benefit of enhanced weight loss.